Company Presentation
Recolony AG
| Country: | Switzerland |
| Category: | Emerging Biotech Company |
| Room: | Sydney |
| Date: | April 25, 2023 |
| Time: | 13:30-13:45 |
| Website: | https://www.recolony.ch/ |
| Speaker: | Egle Katkeviciute, Chief Scientific Officer |
Company profile
At Recolony, we focus our efforts in developing cancer therapies that primarily consist of selected commensal bacteria of the gut microbiota. By harnessing the potential of beneficial gut microbiota, Recolony aims to develop a completely new class of drugs for the treatment and prevention of cancer. Our aim is to shift the paradigm of cancer treatment away from single-target-drugs towards a gut microbiota guided activation of the immune system.
